VivoSense

10/19/2023

VivoSense published a new Karger review article, The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder. Check it out! https://hubs.la/Q026823x0 ,

Karger Publication: The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder

10/05/2023

Learn about VivoSense's ongoing work developing digital measures of function for older adults with disease funded by
https://hubs.la/Q024xltM0

09/28/2023

Study reveals how wearable sensor data can improve the holistic assessment of physical function in cancer survivors. View the presentation https://hubs.la/Q023MdXW0

Study reveals how wearable sensor data can improve the holistic assessment of physical function in cancer survivors. View the presentation.

09/21/2023

It's World Alzheimer's Day! Our long-term goal is to qualify a real-world digital measure of functioning for patients with AD. https://hubs.la/Q0231dV90

09/13/2023

CancerX announced its strategic priorities for 2023-2024 to achieve President Biden’s national goals for the Cancer Moonshot of reducing the death rate from cancer by at least 50 percent over the next 25 years. Learn more about the mission: https://hubs.la/Q0228VxW0

09/07/2023

VivoSense® Software 3.6 update is live and ready! We are committed to continually expanding its capabilities to provide visualization and analysis for data from wearable sensors in clinical research. https://hubs.la/Q021y7h80

New version available! VivoSense® software v3.6 is an affordable, regulatory compliant platform for researchers that need to analyze wearable sensor data.

08/24/2023

New paper! It outlines a roadmap of the research needed to develop, validate, and deploy digital measures of real-world physical behavior in Alzheimer’s clinical trials. https://hubs.la/Q02074xG0

In collaboration with researchers at the University of Massachusetts Amherst, we published a new review paper in the Journal of Alzheimer’s Disease.

08/10/2023

Here's a quick snapshot of Robert Wright and Jana Von Hehn's presentation about how to use biosensors to discover novel digital biomarkers with a patient-centric approach. View the overview and slides >> https://hubs.la/Q01-gDdG0

Robert Wright and Jana Von Hehn demonstrate how to use biosensors to discover novel digital biomarkers with a patient-centric approach.

08/02/2023

We are thrilled to announce Colin Bower will join us as Chief Executive Officer! He is a proven leader in healthcare technology, and his complementary experience and skills will drive VivoSense’s growth as we continue to develop novel digital biomarkers. https://hubs.la/Q01ZLZNr0

Colin is a proven leader in healthcare technology and his experience and skills will drive our growth in novel digital biomarkers development.

07/13/2023

DATAcc announced the release of the Analytical Validation Library recently! Kate Lyden, PhD and VivoSense CSO collaborated with other industry leaders to show 'what good looks like’ regarding high-quality analytical validation. Check out this critical new resource >> https://hubs.la/Q01XDzHj0

Learn about the release of the Analytical Validation Library by DATAcc, which aims to establish industry-wide standards for analytically validated DHTs.